ORTUVO LLC

Medtech

A scalable in vitro toxicity assay platform using cellular-electrode interface bioprinting technology for rapid human toxicity testing of drugs and consumer products

Grants
$256K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Fully Screen Printed Electric Cell-Substrate Impedance Sensing Toxicity Assay$256,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1054MILLION MARKER WELLNESS INC.——
1055BIOMED CONSULTING, INC.——
1056INOVODEL, INC.——
1057ORTUVO LLC——
1058PERCEPTRON HEALTH, INC.——
1059Dissectables LLC——
1060STREAM DX, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.